The distribution of human papilloma virus infection in women with cervical histological abnormalities from an area with high incidentce of cervical cancer

Ethiopian Medical Journal

Volumn 43, Issue 3, 2005, Pages 151-158

  Fanta, Bahiru Ergicho ^a  

^a UNIVERSITY OF GONDAR   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOPSY; ETHIOPIA; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; INCIDENCE; ISOLATION AND PURIFICATION; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; UTERINE CERVIX; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

BIOPSY; CERVIX UTERI; ETHIOPIA; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; INCIDENCE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 33644875245     PISSN: 00141755     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Eduardo LF, Eliane DF, Alex F. Cervical cancer epidemiology, prevention and the Role of human papolloma virus Infection. Can med Assoc. J April 3, 2001: 164-7
2. International Agency for research on cancer (IARC) working groups on the evaluation of carcinogenic risks to humans- Human papilloma virus Lyon, IARC Monographs, 1995: 64:277-282, 1995
3. Porkin DM, pisanip, Ferlay J. Estimates of the worldwide incidence of 18 major cancers in 2000 Int.J cancer 2002; 54: 596-606.
4. France EL, Villa LL, Richardson D, etal. Epidemiology of cervical human papilloma virus infection. J Infect Dis 1999; 180: 1415-23
5. Munoz N etal. The causal Link between human papilloma virus and invasive cervical cancer: a population based case control study in Colombia and Spain. Int. J cancer 1992; 52: 743-9
6. Berkel J. proceedings of the second national workshop on cervical cancer screening. Chronic dis can 1992; 13:51-41
7. Husnjak K, Grce M, Magpic L. Comparison of five different polymerase chain reaction methods for detection of human papilloma virus in cervical cell specimens J Virus meth 2000; 88: 125-34,
8. Hwang T. Detection and typing of human papilloma virus DNA by PCR using consensus primers in various cervical lesions of Korean women. J Korean Med. Sci 1999; 14: 593-9
9. Bernad D, H.U, etal. Identification and assessment of known and novel human papilloma viruses by PCR amplification, restrictions fragment length polymorphism, Nucleotide sequence, and phylogenic algoriths. J Infect. Dis, 2004; 170: 1007-85,
10. Ratnam S, France EL. Human papilloma virus testing for primary screening of cervical cancer precursors. Cancer epidem. Biomarkers prev. 2000; 9:945-51
11. Sasagowa etal. High risk and multiple human papilloma Virus infections associated with cervical abnormalities in Japanese Women. Cancer epidem. Biomarkers prev; 2001, 10: 45-52,
12. Schiffman etal. Epidemiologic evidence snowing that human papilloma virus infections causes most cervical intera- epithelial neoplasia. J nat cancer Inst 1, 1993; 85: 958-64
13. Slattery M, etal. Sexual activity, contraception, genital infections and cervical cancer: support for a sexually transmitted disease hypothesis. Amer. J Epidem 1998;130: 248-58,
14. Ponten J, Quo Z. Precancer of the human cervix. Cancer surv. 1998; 32: 201-229
15. Zur H Hausen M. Haman papilloma viruses in the pathogenesis of anogenital cancer. Virology 1991; 184: 9-13
16. Walboomers JM, etal, Human papilloma virus is a necessary cause of invasive cervical cancer worldwide J. pathol, 1999; 189: 12-9.
17. Munoz N. Human papilloma virus and cancer: the epidemiological evidence. J clin. virol 2000; 19 (2): 1-5
18. Clifford GM, etal. Human papilloma virus types in invasive cervical cancer worldwide: a meta analysis. Br. J cancer 2003; 88: 63-73
19. Kristiansen E, etal. Human papilloma virus infection in Norwegian women with cervical cancer APMIS 1994; 102: 122-28
20. Rantam S, France E, Ferency A. Human papilloma virus testing for primary screening of cervical cancer precursors. Epidemiology Biomarkers Prev. 200; 9: 945-51
21. Asato T, etal. A large case-control study of cervical cancer risk associated with Human popilloma virus infection in Japan; by nucleotide sequencing-based genotyping. J Infect Dis. 2004; 15:1829-32
22. Naucler P, etal. Human papilloma virus genotypes in cervical cancers in Mozambique. J Gen virol 2004; 85: 2189-91
23. Peng S, etal. Development of a DNA vaccine targeting human papilloma virus type 16 oncoprotein J Gen virol. 2004; 84: 1972-76
24. William W, etal. Life style, environmental and genetic susceptibility to cervical cancer. American Journal of pathology 2003; 18: 138-42.
25. kevin A, etal. A phase I study to evaluate a human papilloma virus type 18 L1 VLP vaccine. Vaccine 2004; 22: 3004-7